Dublin-based Aerska launched on Wednesday with $21 million in seed funding and a technology designed to shuttle RNA ...

Lethal and rescuer genes are defined as genes that when inactivated result in cell death or enhanced cell growth, respectively. The ability to identify these genes in large-scale automated screening ...

According to DataM Intelligence, "The RNA-Based Therapies Market Size, valued at USD 90.56 billion in 2024, is projected to reach USD 213.54 billion by 2033, expanding at a CAGR of 10.0% during the ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed a request for regulatory clearance to initiate a Phase 1/2a clinical trial of ARO-DIMER-PA, the company’s ...

Aerska has emerged from stealth and announced a $21m seed raise to advance its pipeline of medicines and grow its Irish and UK operations.

Using RNA to interfere with a gene’s expression of disease-causing proteins is a validated therapeutic approach, but so far, the products in this drug class only address liver proteins. Reducing ...

SAN FRANCISCO (AP) _ The biotechnology field is littered with the debris of would-be miracle cures. These days, the buzz is building around a technology called ``RNA interference,'' whose legions of ...

The U.S. Environmental Protection Agency has approved the registration of Norroa, the first-ever RNA-based treatment for ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "RNA Interference Market by Type, by Application, by End-user, and by Region" report has been added to ...

Drawing on decades of data across multiple states, University of Arizona entomologists found that field-evolved resistance to ...

Dublin, May 21, 2025 (GLOBE NEWSWIRE) -- The "RNAi Technology Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering.